Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The mildest form of autism spectrum disorder, characterized by difficulties with social communication and restricted, repetitive behaviors, requiring minimal support for daily functioning.
Biomarker and diagnostic research for autism spectrum disorder 1 has been reported in the published literature.
13 clinical trials registered, 1 recruiting. Interventions under study include other interventions and medical devices. Pipeline includes 8 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06227780](https://clinicaltrials.gov/study/NCT06227780) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
European rare disease database
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
NA |
Children's Hospital Medical Center, Cincinnati |
RECRUITING |
297 publications have been identified in PubMed for autism spectrum disorder 1. Research spans Basic Science / Preclinical (29%), Review / Meta-Analysis (27%), and Epidemiology / Natural History (21%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 86 | 29% |
Research summaries | 80 | 27% |
Disease patterns and progression | 62 | 21% |
Testing and diagnosis research | 32 | 11% |
Clinical study results | 18 | 6% |
Other research | 8 | 3% |
New treatment approaches | 7 | 2% |
Patient case studies | 4 | 1% |
Muiño Tato A (2026). [PMID: 42052784](https://pubmed.ncbi.nlm.nih.gov/42052784/). *Rev Neurol*. [Review / Meta-Analysis]
Katiraei P (2026). [PMID: 41751904](https://pubmed.ncbi.nlm.nih.gov/41751904/). *Int J Mol Sci*. [Review / Meta-Analysis]
Bhalla S (2026). [PMID: 41575614](https://pubmed.ncbi.nlm.nih.gov/41575614/). *Molecular neurobiology*. [Clinical Trial Publication]
Rezende LV (2026). [PMID: 41851912](https://pubmed.ncbi.nlm.nih.gov/41851912/). *Dev Med Child Neurol*. [Case Report / Case Series]
Laurén K (2026). [PMID: 41956431](https://pubmed.ncbi.nlm.nih.gov/41956431/). *Neuroimage*. [Basic Science / Preclinical]
Buchignani B (2026). [PMID: 41889286](https://pubmed.ncbi.nlm.nih.gov/41889286/). *Dev Med Child Neurol*. [Epidemiology / Natural History]
Burrows CA (2026). [PMID: 40653186](https://pubmed.ncbi.nlm.nih.gov/40653186/). *Biol Psychiatry*. [Review / Meta-Analysis]
Vasconcelos MM (2026). [PMID: 41101354](https://pubmed.ncbi.nlm.nih.gov/41101354/). *Jornal de pediatria*. [Basic Science / Preclinical]
Li N (2026). [PMID: 41443491](https://pubmed.ncbi.nlm.nih.gov/41443491/). *Environ Res*. [Epidemiology / Natural History]
Fan GZ (2026). [PMID: 40540000](https://pubmed.ncbi.nlm.nih.gov/40540000/). *European archives of psychiatry and clinical neuroscience*. [Epidemiology / Natural History]